Differential expression of miR-194. by Jun Xu (45543)

“…<p>(A) Bioinformatics study shows that miR-194 sequence is partially complementary to the 3′-UTR of Sox5 mRNA. …”

The percentage of tPSA levels over 20 ng/mL in PCa patients. by Rong Na (297455)

“…<p>There was a significant decrease in the percentage of tPSA levels over 20 ng/mL in PCa patients from 2003 to 2010 (<i>P_trend</i> = 2.26×10⁻⁵).…”

Rotation behavior in apomorphine-induced PD rats. by Yu-Jen Chang (167677)

“…<p>A significant decrease in the number of apomorphine-induced rotations was observed in rats grafted with AFSCs (black bar) compared to the sham control group (gray bar) after 12 -weeks after transplantation. …”

BDNF immunoreactivity in the distal ON after 6 weeks of diabetes. by Damián Dorfman (293002)

“…<p>In diabetic animals housed in SE, a significant decrease in BDNF immunostaining was observed in the distal portion of the ON, whereas in the ON from diabetic animals housed in EE, BDNF immunoreactivity was similar to that found in non-diabetic animals kept in SE or EE. …”

Summary of methylation data. by Linda Sterrenburg (194954)

“…<p>Panel summarizing methylation of the <i>Crf</i> gene at sites in 5′ flanking region, exon 1, intron and exon 2 of <i>Crf,</i> in the PVN, BST and CeA. …”

Analysis of cell cycle progression in irradiated hES cells. by Mary L. Lan (293893)

“…<p>Exponentially growing cultures of hES cells exposed to 5 Gy showed an increase in the proportion of cells in G2/M and a decrease in the proportion of cells in G1. …”

Expression of TGFβ signaling related genes. by Olena Preobrazhenska (317896)

“…<p>Gene expression for CTGF, a downstream mediator of TGFβ signaling, and for TGFβ receptors 1 (Alk5), 2, and 3. …”

Figures 1-6, Extended Data Figures 1-7 by Xinyi Zhang (14514942)

“…B) Grip strength (n=8). C) Maximal running speed (n=10). D) Peak oxygen uptake (VO2 peak) before tumor injection, one week after tumor injection and three weeks after tumor injection (n=5). …”

OVA-induced airway inflammation is attenuated by oral administration of SH-2251. by Junpei Suzuki (403143)

“…<p><b>(A)</b>, Decreased infiltration of eosinophils in the BAL fluid of asthmatic SH-2251-administered mice. …”

HS/heparin GAGs inhibit the development of NV in OIR. by Koji M. Nishiguchi (147632)

“…HIII reduced HS in the ocular fluid by 87.3% <i>in vivo</i> (left; N = 5) and 80.2% <i>in vitro</i> (right; N = 5). (B–C) Measurement of area covered with retinal vessels. …”

Image_1_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Table_3_Global burden of lower respiratory infections during the last three decades.DOC by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Presentation_2_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Image_11_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Image_14_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Image_9_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Table_2_Global burden of lower respiratory infections during the last three decades.DOC by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Image_8_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Table_1_Global burden of lower respiratory infections during the last three decades.DOCX by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Image_15_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”